|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.70 EUR | +0.09% |
|
+4.43% | -8.07% |
| 06-12 | Dollarama Price Target Raised to $228 at CIBC | MT |
| 06-12 | TSX futures rise after Trump signals Middle East peace deal | RE |
| Fiscal Period: February | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 14.89 | 16.15 | 17.61 | 16.82 | 15.55 | |||||
Return on Total Capital | 16.79 | 18.4 | 19.81 | 18.62 | 17.12 | |||||
Return On Equity % | 493.39 | -4.26K | 493.8 | 148.94 | 99.04 | |||||
Return on Common Equity | 493.39 | -4.26K | 493.8 | 148.94 | 99.04 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 47.31 | 46.53 | 47.43 | 45.12 | 45.05 | |||||
SG&A Margin | 17.64 | 17.25 | 17.28 | 14.5 | 15.07 | |||||
EBITDA Margin % | 24.72 | 24.55 | 25.98 | 26.46 | 25.51 | |||||
EBITA Margin % | 22.79 | 22.71 | 24.21 | 24.65 | 24.07 | |||||
EBIT Margin % | 22.79 | 22.71 | 24.21 | 24.65 | 24.07 | |||||
Income From Continuing Operations Margin % | 15.31 | 15.87 | 17.22 | 18.22 | 18.05 | |||||
Net Income Margin % | 15.31 | 15.87 | 17.22 | 18.22 | 18.05 | |||||
Net Avail. For Common Margin % | 15.31 | 15.87 | 17.22 | 18.22 | 18.05 | |||||
Normalized Net Income Margin | 13.41 | 13.33 | 14.39 | 15.08 | 15.11 | |||||
Levered Free Cash Flow Margin | 17.98 | 9.73 | 15.97 | 15.87 | 16.02 | |||||
Unlevered Free Cash Flow Margin | 19.24 | 11.15 | 17.8 | 17.69 | 17.77 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.05 | 1.14 | 1.16 | 1.09 | 1.03 | |||||
Fixed Assets Turnover | 2.02 | 2.13 | 2.24 | 2.18 | 2.13 | |||||
Receivables Turnover (Average Receivables) | 185.05 | 122.42 | 132.2 | 162.13 | 170.45 | |||||
Inventory Turnover (Average Inventory) | 3.74 | 3.49 | 3.29 | 3.83 | 3.94 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.79 | 0.99 | 1.93 | 1.18 | 1.13 | |||||
Quick Ratio | 0.11 | 0.14 | 0.55 | 0.23 | 0.28 | |||||
Operating Cash Flow to Current Liabilities | 1.17 | 0.75 | 2.26 | 1.62 | 1.31 | |||||
Days Sales Outstanding (Average Receivables) | 1.97 | 2.97 | 2.75 | 2.29 | 2.14 | |||||
Days Outstanding Inventory (Average Inventory) | 97.44 | 104.28 | 110.57 | 96.87 | 92.4 | |||||
Average Days Payable Outstanding | 10.82 | 10.06 | 12.69 | 11.94 | 10.66 | |||||
Cash Conversion Cycle (Average Days) | 88.58 | 97.2 | 100.63 | 87.22 | 83.88 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -5.48K | 14.85K | 1.14K | 396.35 | 370.61 | |||||
Total Debt / Total Capital | 101.86 | 99.33 | 91.92 | 79.85 | 78.75 | |||||
LT Debt/Equity | -4.64K | 12.26K | 1.07K | 349.85 | 317.3 | |||||
Long-Term Debt / Total Capital | 86.35 | 82.02 | 86.49 | 70.49 | 67.42 | |||||
Total Liabilities / Total Assets | 101.62 | 99.41 | 92.76 | 81.67 | 80.74 | |||||
EBIT / Interest Expense | 10.82 | 9.95 | 8.25 | 8.43 | 8.56 | |||||
EBITDA / Interest Expense | 13.86 | 12.63 | 10.24 | 10.49 | 10.68 | |||||
(EBITDA - Capex) / Interest Expense | 12.36 | 11.47 | 8.78 | 9.35 | 9.46 | |||||
Total Debt / EBITDA | 2.86 | 2.89 | 2.46 | 2.4 | 2.48 | |||||
Net Debt / EBITDA | 2.8 | 2.83 | 2.28 | 2.33 | 2.32 | |||||
Total Debt / (EBITDA - Capex) | 3.21 | 3.19 | 2.87 | 2.69 | 2.79 | |||||
Net Debt / (EBITDA - Capex) | 3.14 | 3.11 | 2.66 | 2.61 | 2.62 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 7.56 | 16.67 | 16.12 | 9.3 | 13.14 | |||||
Gross Profit, 1 Yr. Growth % | 7.18 | 14.74 | 18.37 | 10.73 | 12.96 | |||||
EBITDA, 1 Yr. Growth % | 7.13 | 15.88 | 23.02 | 11.33 | 9.08 | |||||
EBITA, 1 Yr. Growth % | 6.66 | 16.29 | 23.94 | 11.29 | 10.47 | |||||
EBIT, 1 Yr. Growth % | 6.66 | 16.29 | 23.94 | 11.29 | 10.47 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 17.51 | 20.91 | 26.01 | 15.64 | 12.06 | |||||
Net Income, 1 Yr. Growth % | 17.51 | 20.91 | 26.01 | 15.64 | 12.06 | |||||
Normalized Net Income, 1 Yr. Growth % | 9.37 | 16.02 | 25.53 | 14.51 | 13.38 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 20.44 | 26.61 | 28.99 | 16.85 | 13.7 | |||||
Accounts Receivable, 1 Yr. Growth % | 27.81 | 114.36 | -42.31 | 43.62 | -17.45 | |||||
Inventory, 1 Yr. Growth % | -6.3 | 61.98 | -4.22 | 0.47 | 19.77 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 9.15 | 11.61 | 9.47 | 15.2 | 15.84 | |||||
Total Assets, 1 Yr. Growth % | -3.79 | 18.61 | 9.21 | 23.16 | 16.59 | |||||
Tangible Book Value, 1 Yr. Growth % | 72.68 | -9.8 | -40.42 | -154.35 | 70.09 | |||||
Common Equity, 1 Yr. Growth % | -119.72 | -143.02 | 1.24K | 212 | 22.52 | |||||
Cash From Operations, 1 Yr. Growth % | 19.95 | -25.03 | 76.17 | 7.39 | 7.12 | |||||
Capital Expenditures, 1 Yr. Growth % | -2.33 | -1.99 | 88.49 | -15.77 | 16.88 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 20.68 | -36.69 | 93.8 | 8.27 | 13.82 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 18.65 | -32.37 | 85.61 | 8.65 | 13.32 | |||||
Dividend Per Share, 1 Yr. Growth % | 12.4 | 9.94 | 28.03 | 29.94 | 15 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 6.93 | 12.02 | 16.4 | 12.66 | 11.2 | |||||
Gross Profit, 2 Yr. CAGR % | 7.13 | 10.9 | 16.54 | 10.95 | 11.84 | |||||
EBITDA, 2 Yr. CAGR % | 7.91 | 11.42 | 19.32 | 17.03 | 10.2 | |||||
EBITA, 2 Yr. CAGR % | 7.26 | 11.37 | 19.97 | 17.44 | 10.88 | |||||
EBIT, 2 Yr. CAGR % | 7.26 | 11.37 | 19.97 | 17.44 | 10.88 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 8.43 | 19.2 | 23.44 | 20.72 | 13.84 | |||||
Net Income, 2 Yr. CAGR % | 8.43 | 19.2 | 23.44 | 20.72 | 13.84 | |||||
Normalized Net Income, 2 Yr. CAGR % | 9.81 | 12.64 | 20.59 | 19.9 | 13.94 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 10.67 | 23.49 | 27.79 | 22.77 | 15.27 | |||||
Accounts Receivable, 2 Yr. CAGR % | -13.34 | 65.52 | 11.2 | -8.98 | 8.88 | |||||
Inventory, 2 Yr. CAGR % | -2.65 | 23.2 | 24.56 | -1.9 | 9.69 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.85 | 10.38 | 10.54 | 12.3 | 15.52 | |||||
Total Assets, 2 Yr. CAGR % | 4.57 | 6.82 | 13.81 | 15.98 | 19.83 | |||||
Tangible Book Value, 2 Yr. CAGR % | -0.78 | 24.8 | -26.69 | -43.1 | -3.85 | |||||
Common Equity, 2 Yr. CAGR % | -15.37 | -70.87 | 140.16 | 546.73 | 95.52 | |||||
Cash From Operations, 2 Yr. CAGR % | 20.63 | -1.11 | 14.92 | 37.55 | 7.26 | |||||
Capital Expenditures, 2 Yr. CAGR % | 8.84 | -2.16 | 35.92 | 26 | -0.78 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 16.14 | -12.72 | 9.84 | 45.09 | 11.2 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 14.33 | -10.42 | 11.94 | 42.01 | 11.13 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.92 | 11.16 | 18.64 | 28.98 | 22.24 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.87 | 10.09 | 13.37 | 13.98 | 12.82 | |||||
Gross Profit, 3 Yr. CAGR % | 6.2 | 9.61 | 13.33 | 12.2 | 11.61 | |||||
EBITDA, 3 Yr. CAGR % | 5.57 | 10.5 | 15.11 | 16.6 | 14.32 | |||||
EBITA, 3 Yr. CAGR % | 5.3 | 10.19 | 15.36 | 17 | 15.07 | |||||
EBIT, 3 Yr. CAGR % | 5.3 | 10.19 | 15.36 | 17 | 15.07 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 6.76 | 12.44 | 21.43 | 20.78 | 17.76 | |||||
Net Income, 3 Yr. CAGR % | 6.76 | 12.44 | 21.43 | 20.78 | 17.76 | |||||
Normalized Net Income, 3 Yr. CAGR % | 7.36 | 11.84 | 16.73 | 18.53 | 17.68 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 9.51 | 15.74 | 25.29 | 24.04 | 19.67 | |||||
Accounts Receivable, 3 Yr. CAGR % | -9.85 | 17.2 | 16.48 | 21.1 | -11.89 | |||||
Inventory, 3 Yr. CAGR % | 0.55 | 15.36 | 13.28 | 15.95 | 4.85 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.71 | 9.09 | 10.07 | 12.07 | 13.47 | |||||
Total Assets, 3 Yr. CAGR % | 6.55 | 9.05 | 7.61 | 16.85 | 16.18 | |||||
Tangible Book Value, 3 Yr. CAGR % | -7.08 | -3.88 | -2.46 | -33.65 | -18.03 | |||||
Common Equity, 3 Yr. CAGR % | -40.74 | -32.46 | 4.38 | 162.05 | 271.44 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.83 | 5.86 | 19.88 | 12.35 | 26.55 | |||||
Capital Expenditures, 3 Yr. CAGR % | -1.16 | 5.1 | 21.74 | 15.88 | 22.88 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 25.89 | -5.22 | 13.23 | 9.44 | 33.96 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 23.07 | -4.02 | 14.14 | 10.83 | 31.85 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.94 | 7.92 | 16.52 | 22.29 | 24.14 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.88 | 9.12 | 10.58 | 11.11 | 12.5 | |||||
Gross Profit, 5 Yr. CAGR % | 7.31 | 8 | 10.22 | 10.14 | 11.33 | |||||
EBITDA, 5 Yr. CAGR % | 9.07 | 8.81 | 10.87 | 13.04 | 13.12 | |||||
EBITA, 5 Yr. CAGR % | 8.86 | 8.72 | 10.94 | 13 | 13.54 | |||||
EBIT, 5 Yr. CAGR % | 8.86 | 8.72 | 10.94 | 13 | 13.54 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.28 | 9.07 | 13.14 | 15.68 | 18.33 | |||||
Net Income, 5 Yr. CAGR % | 8.28 | 9.07 | 13.14 | 15.68 | 18.33 | |||||
Normalized Net Income, 5 Yr. CAGR % | 8.69 | 8.53 | 12.47 | 14.96 | 15.61 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.01 | 12.67 | 16.48 | 18.5 | 21.18 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.28 | 29.82 | -1.95 | 5.93 | 13.38 | |||||
Inventory, 5 Yr. CAGR % | 4.88 | 14.29 | 9.54 | 8.12 | 11.83 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 38.68 | 38.5 | 8.83 | 10.36 | 12.22 | |||||
Total Assets, 5 Yr. CAGR % | 16.87 | 20.03 | 9.4 | 11.77 | 12.34 | |||||
Tangible Book Value, 5 Yr. CAGR % | 4.63 | -5.11 | -15.49 | -22.06 | -3.02 | |||||
Common Equity, 5 Yr. CAGR % | -8.02 | -35.39 | 3.71 | 66.74 | 34.17 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.11 | 6.4 | 17.42 | 17.55 | 14.66 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.8 | 8.4 | 12.27 | 13.01 | 12.18 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 16.11 | 0.43 | 19.14 | 12 | 12.49 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.51 | 2.26 | 18.49 | 12.22 | 12.92 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.04 | 8.08 | 12.1 | 15.9 | 18.78 |
- Stock Market
- Stocks
- DOL Stock
- DR3 Stock
- Financials Dollarama Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















